<n-docbody><doc bill="Y"><content.metadata.block><cmd.identifiers><cmd.cites><cmd.second.line.cite><bop/><bos/>Multidistrict Lit Man § 6:7<eos/><eop/></cmd.second.line.cite></cmd.cites></cmd.identifiers></content.metadata.block><prop.block><prop.head toc-guid=""><bop/><bos/><headtext>Multidistrict Litigation Manual</headtext><eos/><eop/></prop.head><content.metadata.block><cmd.dates><cmd.currency.default iso.d="20190501"><bop/><bos/>May 2019 Update<eos/><eop/></cmd.currency.default></cmd.dates></content.metadata.block><author.line><bop/><bos/><author>David F. Herr[<footnote.reference refid="If5163b116b3e11e99b03e53d6dd36aa2">a0</footnote.reference>]</author><eos/><eop/></author.line><prop.head toc-guid="I97b7f560933b11da99e2b07024dacc26"><bop/><bos/><label.name>Part</label.name><label.designator>I.</label.designator><headtext>Handling Cases Before the Judicial Panel on Multidistrict Litigation</headtext><eos/><eop/></prop.head><prop.head toc-guid="I1c3ad730933c11da99e2b07024dacc26"><bop/><bos/><label.name>Chapter</label.name><label.designator>6.</label.designator><headtext>Selection of a Transferee District</headtext><eos/><eop/></prop.head></prop.block><message.block><include.copyright n-include_collection="w_wlnv_msg" n-include_guid="I1DA35ED81DD211B281BAD200220BDFCA">Copyright (c) 2017 Thomson/RIA All rights reserved.</include.copyright></message.block><section><section.front><doc.title toc-guid="I94f39c74e1e311da9c26e67ca3b71335"><head parent="doc.title"><bop/><bos/><label.name>§ </label.name><label.designator>6:7.</label.designator><headtext>Factors articulated by the Panel in selecting transferee district—Centrality</headtext><eos/><eop/></head></doc.title></section.front><section.body><para><bop/><bos/><paratext>A related factor to the location of witnesses and documents is the location of the parties and attorneys. <eos/><bos/>The Panel has expressed its preference for selection of a centrally located transferee district.[<eos/><bos/><footnote.reference refid="If51662206b3e11e99b03e53d6dd36aa2">1</footnote.reference>] This factor can overcome otherwise strongly favored factors.[<eos/><bos/><footnote.reference refid="If516b0406b3e11e99b03e53d6dd36aa2">2</footnote.reference>] In one case the Panel considered logical transferee districts in New York and California and determined to transfer the cases to Illinois because of its central location. <eos/><bos/>The Panel noted <begin.quote ID="QT_0001"/>“that although air travel renders both California and New York readily accessible, there is still something to be said for the convenience of a geographically central forum in coast-to-coast litigation.”<eos/><bos/><end.quote refid="QT_0001"/>[<footnote.reference refid="If516d7506b3e11e99b03e53d6dd36aa2">3</footnote.reference>] The advantages of a geographically central forum increase as the number of actions increase. <eos/><bos/>The Panel has noted this in its decisions, and this factor is accordingly more likely to be relied on by the Panel in a situation involving either many actions or the likelihood that there will be many geographically diverse actions.[<eos/><bos/><footnote.reference refid="If516d7516b3e11e99b03e53d6dd36aa2">4</footnote.reference>] Geographic dispersal of parties and potential witnesses has also been noted by the Panel as resulting in no district standing out as a logical transferee district, making centrality more important.[<eos/><bos/><footnote.reference refid="If516d7526b3e11e99b03e53d6dd36aa2">5</footnote.reference>] Centrality can also be found on a regional basis. <eos/><bos/>In one docket the Panel selected the District of Massachusetts as the transferee district in part because it was centrally located to the pending generally <begin.quote ID="QT_0002"/>“in the eastern part of the United States.”<eos/><bos/><end.quote refid="QT_0002"/>[<footnote.reference refid="If516d7536b3e11e99b03e53d6dd36aa2">6</footnote.reference>] In another case, the Panel selected the District of South Carolina, noting that the pending litigation had “a Southern tilt.”[<eos/><bos/><footnote.reference refid="If516fe606b3e11e99b03e53d6dd36aa2">7</footnote.reference>] For litigation involving a significant foreign component, the Panel may select a forum particularly accessible to overseas air travel.[<eos/><bos/><footnote.reference refid="If516fe616b3e11e99b03e53d6dd36aa2">8</footnote.reference>] The Panel looked to the convenience of both foreign and domestic parties and counsel in making this decision.<eos/></paratext><eop/></para><para><bop/><bos/><paratext>Geographic proximity may be measured in units other than miles. <eos/><bos/>The Panel has recognized that transfer and consolidation impose travel burdens on the litigants and their attorneys. <eos/><bos/>Proximity may be evaluated in terms of ease of access by air travel. <eos/><bos/>A location with a large airport offering frequent air service to the other centers of activity in the case may be much more convenient than a location physically closer to the witnesses or documents but which is much more difficult to get to.[<eos/><bos/><footnote.reference refid="If516fe626b3e11e99b03e53d6dd36aa2">9</footnote.reference>] This factor can be considered by the Panel, and will be if the evidence is placed before it. <eos/><bos/>For this purpose photocopies of the relevant pages of the Official Airline Guide or similar publication showing extent of air service may be attached to an affidavit and filed for consideration by the Panel. <eos/><bos/>It is not necessary, however, to go through this exercise to show that New York&apos;s LaGuardia or Chicago&apos;s O&apos;Hare airports offer better and more frequent air service than is available at Des Moines. <eos/><bos/>The Panel can take judicial notice of those facts. <eos/><bos/>For comparing service at Des Moines to that at Indianapolis, however, some concrete information may be useful to the Panel.<eos/></paratext><eop/></para><para><bop/><bos/><paratext>The Panel has also expressed its preference for an urban location for transferred litigation rather than a rural one, since the urban location is presumed to be more accessible and convenient to a greater number of witnesses, parties, and attorneys.[<eos/><bos/><footnote.reference refid="If516fe636b3e11e99b03e53d6dd36aa2">10</footnote.reference>] The Panel noted, however, that all other factors affecting selection of a transferee district balanced and were equal.<eos/></paratext><eop/></para><para><bop/><bos/><paratext>Proximity may also affect the Panel&apos;s decision if two logical transferee districts are near each other. <eos/><bos/>In that event, other factors normally favoring one or the other may be diminished because of the proximity of the two. <eos/><bos/>For example, if two districts are adjacent, the opportunity to coordinate with other federal proceedings may be present even if transfer is not ordered to the district in which the other proceedings are pending.[<eos/><bos/><footnote.reference refid="If51725706b3e11e99b03e53d6dd36aa2">11</footnote.reference>] The Panel has also looked to the preference of the parties as evidence of the convenience of an accessible transferee forum.[<eos/><bos/><footnote.reference refid="If51725736b3e11e99b03e53d6dd36aa2">12</footnote.reference>] In one case the Panel transferred to a district adjacent to the logical, central district because the parties had asserted recusal challenges to the judges of that district.[<eos/><bos/><footnote.reference refid="If51725746b3e11e99b03e53d6dd36aa2">13</footnote.reference>] The Panel also articulates a closely related—if not quite identical—criterion: accessibility. <eos/><bos/>The Panel often describes its selected forum as being “accessible,” referring to a district possessing some combination of centrality and ease of access.[<eos/><bos/><footnote.reference refid="If51725756b3e11e99b03e53d6dd36aa2">14</footnote.reference>]</paratext><eos/><eop/></para></section.body></section><author.footnotes><footnote ID="If5163b116b3e11e99b03e53d6dd36aa2"><label.designator>a0</label.designator><footnote.body><para><bop/><bos/><paratext>Maslon Edelman Borman &amp; Brand, LLP, Minneapolis, Minnesota.<eos/></paratext><eop/></para></footnote.body></footnote></author.footnotes><footnote.block><footnote ID="If51662206b3e11e99b03e53d6dd36aa2"><label.designator>1</label.designator><footnote.body><para><bop/><bos/><paratext><ital>See, e.g.</ital>, <cite.query w-src-number="0304914068" w-serial-number="2043740151" w-seq-number="00001" w-ref-type="RP" w-pub-number="0007903" ID="I650e96716b3e11e99779f698461214a6">In re Dealer Management Systems Antitrust Litigation, 291 F. Supp. 3d 1367 (U.S.J.P.M.L. 2018)</cite.query>; <cite.query w-src-number="0304914068" w-serial-number="2043332699" w-seq-number="00002" w-ref-type="RP" w-pub-number="0007903" ID="I650e96736b3e11e99779f698461214a6">In re National Prescription Opiate Litigation, 290 F. Supp. 3d 1375 (U.S.J.P.M.L. 2017)</cite.query>; <cite.query w-src-number="0304914068" w-serial-number="2043332735" w-seq-number="00003" w-ref-type="RP" w-pub-number="0007903" ID="I650e96756b3e11e99779f698461214a6">In re Sonic Corp. Customer Data Security Breach Litigation, 276 F. Supp. 3d 1382 (U.S.J.P.M.L. 2017)</cite.query>; <cite.query w-src-number="0304914068" w-serial-number="2042803478" w-seq-number="00004" w-ref-type="RP" w-pub-number="0007903" ID="I650e96776b3e11e99779f698461214a6">In re CenturyLink Residential Customer Billing Disputes Litigation, 280 F. Supp. 3d 1383 (U.S.J.P.M.L. 2017)</cite.query>; <cite.query w-src-number="0304914068" w-serial-number="2042803426" w-seq-number="00005" w-ref-type="RP" w-pub-number="0007903" ID="I650e96796b3e11e99779f698461214a6">In re Samsung Top-Load Washing Machine Marketing, Sales Practices and Products Liability Litigation, 278 F. Supp. 3d 1376 (U.S.J.P.M.L. 2017)</cite.query>; <cite.query w-src-number="0304914068" w-serial-number="2042304417" w-seq-number="00006" w-ref-type="RP" w-pub-number="0007903" ID="I650e967b6b3e11e99779f698461214a6">In re Epipen (Epinephrine Injection, USP) Marketing, Sales Practices and Antitrust Litigation, 268 F. Supp. 3d 1356 (U.S.J.P.M.L. 2017)</cite.query>; <cite.query w-src-number="0304914068" w-serial-number="2039935897" w-seq-number="00007" w-ref-type="RP" w-pub-number="0007903" ID="I650e967d6b3e11e99779f698461214a6">In re Taxotere (Docetaxel) Products Liability Litigation, 220 F. Supp. 3d 1360 (U.S.J.P.M.L. 2016)</cite.query>; <cite.query w-src-number="0304914068" w-serial-number="2038992583" w-seq-number="00008" w-ref-type="RP" w-pub-number="0007903" ID="I650e967f6b3e11e99779f698461214a6">In re Dollar General Corp. Motor Oil Marketing and Sales Practices Litigation, 190 F. Supp. 3d 1361 (U.S.J.P.M.L. 2016)</cite.query>; <cite.query w-src-number="0304914068" w-serial-number="2038641650" w-seq-number="00009" w-ref-type="RP" w-pub-number="0007903" ID="I650e96816b3e11e99779f698461214a6">In re Genentech Herceptin (trastuzumab) Marketing and Sales Practices Litigation, 178 F. Supp. 3d 1374 (U.S.J.P.M.L. 2016)</cite.query>; <cite.query w-src-number="0304914068" w-serial-number="2037790656" w-seq-number="00010" w-ref-type="RP" w-pub-number="0007903" ID="I650e96836b3e11e99779f698461214a6">In re Ashley Madison Customer Data Security Breach Litigation, 148 F. Supp. 3d 1378 (J.P.M.L. 2015)</cite.query>; <cite.query w-src-number="0304914068" w-serial-number="2035414674" w-seq-number="00011" w-ref-type="RP" w-pub-number="0007903" ID="I650e96856b3e11e99779f698461214a6">In re Rust-Oleum Restore Marketing, Sales Practices and Products Liability Litigation, 84 F. Supp. 3d 1383 (U.S.J.P.M.L. 2015)</cite.query>; <cite.query w-src-number="0304914068" w-serial-number="2035757729" w-seq-number="00012" w-ref-type="RP" w-pub-number="0007903" ID="I650e96876b3e11e99779f698461214a6">In re: TD Bank, N.A., Debit Card Overdraft Fee Litigation, 96 F. Supp. 3d 1378 (U.S.J.P.M.L. 2015)</cite.query>; <cite.query w-src-number="0304914068" w-serial-number="2035414681" w-seq-number="00013" w-ref-type="RP" w-pub-number="0007903" ID="I650e96896b3e11e99779f698461214a6">In re: Caribbean Cruise Line, Inc., Telephone Consumer Protection Act (TCPA) Litigation, 89 F. Supp. 3d 1356 (U.S.J.P.M.L. 2015)</cite.query>; <cite.query w-src-number="0304914068" w-serial-number="2035414674" w-seq-number="00014" w-ref-type="RP" w-pub-number="0007903" ID="I650e968b6b3e11e99779f698461214a6">In re: Rust-Oleum Restore Marketing, Sales Practices and Products Liability Litigation, 84 F. Supp. 3d 1383 (U.S.J.P.M.L. 2015)</cite.query>; <cite.query w-src-number="0304914068" w-serial-number="2033539088" w-seq-number="00015" w-ref-type="RP" w-pub-number="0007903" ID="I650e968d6b3e11e99779f698461214a6">In re: Keurig Green Mountain Single-Serve Coffee Antitrust Litigation, 24 F. Supp. 3d 1361 (U.S.J.P.M.L. 2014)</cite.query> (district conveniently located); <cite.query w-src-number="0304914068" w-serial-number="2024574556" w-seq-number="00016" w-ref-type="RP" w-pub-number="0004637" ID="I650e968f6b3e11e99779f698461214a6">In re Kaba Simplex Locks Marketing and Sales Practices Litigation, 764 F. Supp. 2d 1339 (J.P.M.L. 2011)</cite.query>; <cite.query w-src-number="0304914068" w-serial-number="2025911115" w-seq-number="00017" w-ref-type="RP" w-pub-number="0004637" ID="I650e96916b3e11e99779f698461214a6">In re Wells Fargo Wage and Hour Employment Practices Litigation (No. III), 804 F. Supp. 2d 1382 (J.P.M.L. 2011)</cite.query>; <cite.query w-src-number="0304914068" w-serial-number="2008554313" w-seq-number="00018" w-ref-type="RP" w-pub-number="0004637" ID="I650e96936b3e11e99779f698461214a6">In re Teflon Products Liability Litigation, 416 F. Supp. 2d 1364 (J.P.M.L. 2006)</cite.query>; <cite.query w-src-number="0304914068" w-serial-number="2013155702" w-seq-number="00019" w-ref-type="RP" w-pub-number="0004637" ID="I650e96956b3e11e99779f698461214a6">In re TJX Companies, Inc., 505 F. Supp. 2d 1379 (J.P.M.L. 2007)</cite.query>; <cite.query w-src-number="0304914068" w-serial-number="2006294264" w-seq-number="00020" w-ref-type="RP" w-pub-number="0004637" ID="I650e96976b3e11e99779f698461214a6">In re Merck &amp; Co., Inc., Securities, Derivative &amp; ERISA Litigation, 360 F. Supp. 2d 1375 (J.P.M.L. 2005)</cite.query> (transferee district is relatively convenient); <cite.query w-src-number="0304914068" w-serial-number="2006671811" w-seq-number="00021" w-ref-type="RP" w-pub-number="0004637" ID="I650e96996b3e11e99779f698461214a6">In re Federal Nat. Mortg. Ass&apos;n Securities Derivative &amp; “ERISA” Litigation, 370 F. Supp. 2d 1359 (J.P.M.L. 2005)</cite.query>; <cite.query w-src-number="0304914068" w-serial-number="2006553175" w-seq-number="00022" w-ref-type="RP" w-pub-number="0004637" ID="I650e969b6b3e11e99779f698461214a6">In re Express Scripts, Inc., Pharmacy Benefits Management Litigation, 368 F. Supp. 2d 1356 (J.P.M.L. 2005)</cite.query>; <cite.query w-src-number="0304914068" w-serial-number="2006265212" w-seq-number="00023" w-ref-type="RP" w-pub-number="0004637" ID="I650e969d6b3e11e99779f698461214a6"><ital>In re Insurance Brokerage Antitrust Litigation</ital>, 360 F. Supp. 2d 1371 (J.P.M.L. 2005)</cite.query> (geographic convenience); <cite.query w-src-number="0304914068" w-serial-number="2006265247" w-seq-number="00024" w-ref-type="RP" w-pub-number="0004637" ID="I650e969f6b3e11e99779f698461214a6"><ital>In re Compression Labs, Inc., Patent Litigation</ital>, 360 F. Supp. 2d 1367 (J.P.M.L. 2005)</cite.query> (accessible district); <cite.query w-src-number="0304914068" w-serial-number="2004342722" w-seq-number="00025" w-ref-type="RP" w-pub-number="0004637" ID="I650e96a16b3e11e99779f698461214a6">In re Ocwen Federal Bank FSB Mortgage Servicing Litigation, 314 F. Supp. 2d 1376 (J.P.M.L. 2004)</cite.query>; <cite.query w-src-number="0304914068" w-serial-number="2003915296" w-seq-number="00026" w-ref-type="RP" w-pub-number="0004637" ID="I650e96a36b3e11e99779f698461214a6">In re Farmers Insurance Co., Inc., Insurance Premiums Litigation, 295 F. Supp. 2d 1375 (J.P.M.L. 2003)</cite.query>; <cite.query w-src-number="0304914068" w-serial-number="2003857698" w-seq-number="00027" w-ref-type="RP" w-pub-number="0004637" ID="I650e96a56b3e11e99779f698461214a6">In re National Century Financial Enterprises, Inc., 293 F. Supp. 2d 1375 (J.P.M.L. 2003)</cite.query>; <cite.query w-src-number="0304914068" w-serial-number="2003497641" w-seq-number="00028" w-ref-type="RP" w-pub-number="0004637" ID="I650e96a76b3e11e99779f698461214a6">In re Sulfuric Acid Antitrust Litigation, 270 F. Supp. 2d 1379 (J.P.M.L. 2003)</cite.query>; <cite.query w-src-number="0304914068" w-serial-number="2003470575" w-seq-number="00029" w-ref-type="RP" w-pub-number="0004637" ID="I650e96a96b3e11e99779f698461214a6">In re New Motor Vehicles Canadian Export Antitrust Litigation, 269 F. Supp. 2d 1372 (J.P.M.L. 2003)</cite.query> (centrality trumps absence of any pending actions); <cite.query w-src-number="0304914068" w-serial-number="2003306460" w-seq-number="00030" w-ref-type="RP" w-pub-number="0004637" ID="I650e96ab6b3e11e99779f698461214a6">In re Wireless Telephone 911 Calls Litigation, 259 F. Supp. 2d 1372 (J.P.M.L. 2003)</cite.query>; <cite.query w-src-number="0304914068" w-serial-number="2003231814" w-seq-number="00031" w-ref-type="RP" w-pub-number="0004637" ID="I650e96ad6b3e11e99779f698461214a6">In re Advanced Investment Management, L.P., Pension Fund Management Litigation, 254 F. Supp. 2d 1377 (J.P.M.L. 2003)</cite.query>; <cite.query w-src-number="0304914068" w-serial-number="2002392124" w-seq-number="00032" w-ref-type="RP" w-pub-number="0004637" ID="I650e96af6b3e11e99779f698461214a6">In re Compensation of Managerial, Professional and Technical Employees Antitrust Litigation, 206 F. Supp. 2d 1374 (J.P.M.L. 2002)</cite.query>; <cite.query w-src-number="0304914068" w-serial-number="2002392122" w-seq-number="00033" w-ref-type="RP" w-pub-number="0004637" ID="I650e96b16b3e11e99779f698461214a6">In re Shell Oil Products Co. Dealer Franchise Litigation, 206 F. Supp. 2d 1373 (J.P.M.L. 2002)</cite.query>; <cite.query w-src-number="0304914068" w-serial-number="2002162707" w-seq-number="00034" w-ref-type="RP" w-pub-number="0004637" ID="I650e96b36b3e11e99779f698461214a6">In re McDonald&apos;s Corp. Promotional Games Litigation, 192 F. Supp. 2d 1381 (J.P.M.L. 2002)</cite.query>; <cite.query w-src-number="0304914068" w-serial-number="2001580023" w-seq-number="00035" w-ref-type="RP" w-pub-number="0004637" ID="I650e96b56b3e11e99779f698461214a6">In re Baycol Products Liability Litigation, 180 F. Supp. 2d 1378 (J.P.M.L. 2001)</cite.query>; <cite.query w-src-number="0304914068" w-serial-number="2001989037" w-seq-number="00036" w-ref-type="RP" w-pub-number="0004637" ID="I650e96b76b3e11e99779f698461214a6">In re Aimster Copyright Litigation, 177 F. Supp. 2d 1380 (J.P.M.L. 2001)</cite.query>; <cite.query w-src-number="0304914068" w-serial-number="2001473390" w-seq-number="00037" w-ref-type="RP" w-pub-number="0004637" ID="I650e96b96b3e11e99779f698461214a6">In re American General Life and Accident Ins. Co. Industrial Life Ins. Litigation, 175 F. Supp. 2d 1380 (J.P.M.L. 2001)</cite.query>; <cite.query w-src-number="0304914068" w-serial-number="2001550460" w-seq-number="00038" w-ref-type="RP" w-pub-number="0004637" ID="I650e96bb6b3e11e99779f698461214a6">In re Inter-Op Hip Prosthesis Products Liability Litigation, 149 F. Supp. 2d 931 (J.P.M.L. 2001)</cite.query>; <cite.query w-src-number="0304914068" w-serial-number="2000568381" w-seq-number="00039" w-ref-type="RP" w-pub-number="0000999" ID="I650e96bd6b3e11e99779f698461214a6">In re Cigarette Antitrust Litigation, 2000 WL 1508296 (J.P.M.L. 2000)</cite.query>; <cite.query w-src-number="0304914068" w-serial-number="1995230440" w-seq-number="00040" w-ref-type="RP" w-pub-number="0000345" ID="I650e96bf6b3e11e99779f698461214a6">In re Rio Hair Naturalizer Products Liability Litigation, 904 F. Supp. 1407 (J.P.M.L. 1995)</cite.query>; <cite.query w-src-number="0304914068" w-serial-number="1994055637" w-seq-number="00041" w-ref-type="RP" w-pub-number="0000345" ID="I650e96c16b3e11e99779f698461214a6">In re Temporomandibular Joint (TMJ) Implants Products Liability Litigation, 844 F. Supp. 1553 (J.P.M.L. 1994)</cite.query>; <cite.query w-src-number="0304914068" w-serial-number="1987070350" w-seq-number="00042" w-ref-type="RP" w-pub-number="0000345" ID="I650e96c36b3e11e99779f698461214a6">In re Rail Collision Near Chase, Md. on Jan. 4, 1987, 661 F. Supp. 69 (J.P.M.L. 1987)</cite.query>; <cite.query w-src-number="0304914068" w-serial-number="1979116550" w-seq-number="00043" w-ref-type="RP" w-pub-number="0000345" w-pinpoint-page="1286" ID="I650e96c56b3e11e99779f698461214a6">In re Dept. of Energy Stripper Well Exemption Litigation, 472 F. Supp. 1282, 1286 (J.P.M.L. 1979)</cite.query>; <cite.query w-src-number="0304914068" w-serial-number="1979102466" w-seq-number="00044" w-ref-type="RP" w-pub-number="0000345" w-pinpoint-page="975" ID="I650e96c76b3e11e99779f698461214a6">In re Multi-Piece Rim Products Liability Litigation, 464 F. Supp. 969, 975 (J.P.M.L. 1979)</cite.query>; <cite.query w-src-number="0304914068" w-serial-number="1978122006" w-seq-number="00045" w-ref-type="RP" w-pub-number="0000345" w-pinpoint-page="1170" ID="I650e96c96b3e11e99779f698461214a6">In re Upjohn Co. Antibiotic “Cleocin” Products Liability Litigation, 450 F. Supp. 1168, 1170–1171 (J.P.M.L. 1978)</cite.query>; <cite.query w-src-number="0304914068" w-serial-number="1978104165" w-seq-number="00046" w-ref-type="RP" w-pub-number="0000345" w-pinpoint-page="762" ID="I650e96cb6b3e11e99779f698461214a6">In re Fine Paper Antitrust Litigation, 446 F. Supp. 759, 762 (J.P.M.L. 1978)</cite.query>; <cite.query w-src-number="0304914068" w-serial-number="1976126387" w-seq-number="00047" w-ref-type="RP" w-pub-number="0000345" w-pinpoint-page="386" ID="I650e96cd6b3e11e99779f698461214a6">In re Folding Carton Antitrust Litigation, 415 F. Supp. 384, 386 (J.P.M.L. 1976)</cite.query>; <cite.query w-src-number="0304914068" w-serial-number="1975108632" w-seq-number="00048" w-ref-type="RP" w-pub-number="0000345" w-pinpoint-page="542" ID="I650e96cf6b3e11e99779f698461214a6">In re A. H. Robins Co., Inc. “Dalkon Shield” IUD Products Liability Litigation, 406 F. Supp. 540, 542 (J.P.M.L. 1975)</cite.query>; <cite.query w-src-number="0304914068" w-serial-number="1973107112" w-seq-number="00049" w-ref-type="RP" w-pub-number="0000345" w-pinpoint-page="1088" ID="I650e96d16b3e11e99779f698461214a6">In re Wheat Farmers Antitrust Class Action Litigation, 366 F. Supp. 1087, 1088 (J.P.M.L. 1973)</cite.query>; <cite.query w-src-number="0304914068" w-serial-number="1971105676" w-seq-number="00050" w-ref-type="RP" w-pub-number="0000345" w-pinpoint-page="220" ID="I650e96d36b3e11e99779f698461214a6">In re Government Auto Fleet Sales, 328 F. Supp. 218, 220 (J.P.M.L. 1971)</cite.query>.<eos/></paratext><eop/></para></footnote.body></footnote><footnote ID="If516b0406b3e11e99b03e53d6dd36aa2"><label.designator>2</label.designator><footnote.body><para><bop/><bos/><paratext><ital>See, e.g.</ital>, <cite.query w-src-number="0304914068" w-serial-number="1992137612" w-seq-number="00051" w-ref-type="RP" w-pub-number="0000345" ID="I65112e816b3e11e99779f698461214a6">In re Air Disaster Near Brunswick, Ga., on Apr. 5, 1991, 794 F. Supp. 393 (J.P.M.L. 1992)</cite.query>; <cite.query w-src-number="0304914068" w-serial-number="1980113270" w-seq-number="00052" w-ref-type="RP" w-pub-number="0000345" w-pinpoint-page="928" ID="I65112e836b3e11e99779f698461214a6">In re Air Crash Near Van Cleve, Miss., on Aug. 13, 1977, 486 F. Supp. 926, 928 (J.P.M.L. 1980)</cite.query> (central location preferred to place of crash in air crash).<eos/></paratext><eop/></para></footnote.body></footnote><footnote ID="If516d7506b3e11e99b03e53d6dd36aa2"><label.designator>3</label.designator><footnote.body><para><bop/><bos/><paratext><cite.query w-src-number="0304914068" w-serial-number="1968115792" w-seq-number="00053" w-ref-type="RP" w-pub-number="0000345" w-pinpoint-page="387" ID="I6512dc316b3e11e99779f698461214a6">In re Library Editions of Children&apos;s Books, 297 F. Supp. 385, 387 (J.P.M.L. 1968)</cite.query>; <ital>see also</ital> <cite.query w-src-number="0304914068" w-serial-number="2031762007" w-seq-number="00054" w-ref-type="RP" w-pub-number="0000999" ID="I6512dc336b3e11e99779f698461214a6">In re H &amp; R Block IRS Form 8863 Litigation, 2013 WL 5596032 (J.P.M.L. 2013)</cite.query>; <cite.query w-src-number="0304914068" w-serial-number="2030714943" w-seq-number="00055" w-ref-type="RP" w-pub-number="0004637" ID="I6512dc376b3e11e99779f698461214a6">In re Nickelodeon Consumer Privacy Litigation, 949 F. Supp. 2d 1377 (J.P.M.L. 2013)</cite.query>; <cite.query w-src-number="0304914068" w-serial-number="2030714940" w-seq-number="00056" w-ref-type="RP" w-pub-number="0004637" ID="I6512dc396b3e11e99779f698461214a6">In re Subway Footlong Sandwich Marketing and Sales Practices Litigation, 949 F. Supp. 2d 1369 (J.P.M.L. 2013)</cite.query>; <cite.query w-src-number="0304914068" w-serial-number="2030715063" w-seq-number="00057" w-ref-type="RP" w-pub-number="0004637" ID="I6512dc3b6b3e11e99779f698461214a6">In re Anheuser-Busch Beer Labeling Marketing and Sales Practices Litigation, 949 F. Supp. 2d 1371 (J.P.M.L. 2013)</cite.query>; <cite.query w-src-number="0304914068" w-serial-number="2029450566" w-seq-number="00058" w-ref-type="RP" w-pub-number="0004637" ID="I6512dc3d6b3e11e99779f698461214a6">In re Capital One Telephone Consumer Protection Act Litigation, 908 F. Supp. 2d 1366 (J.P.M.L. 2012)</cite.query>; <cite.query w-src-number="0304914068" w-serial-number="2028387055" w-seq-number="00059" w-ref-type="RP" w-pub-number="0004637" ID="I6512dc3f6b3e11e99779f698461214a6">In re Pradaxa (dabigatran etexilate) Products Liability Litigation, 883 F. Supp. 2d 1355 (J.P.M.L. 2012)</cite.query>; <cite.query w-src-number="0304914068" w-serial-number="2003306460" w-seq-number="00060" w-ref-type="RP" w-pub-number="0004637" ID="I6512dc416b3e11e99779f698461214a6">In re Wireless Telephone 911 Calls Litigation, 259 F. Supp. 2d 1372 (J.P.M.L. 2003)</cite.query>; <cite.query w-src-number="0304914068" w-serial-number="1972106905" w-seq-number="00061" w-ref-type="RP" w-pub-number="0000345" w-pinpoint-page="1166" ID="I6512dc436b3e11e99779f698461214a6">In re Transit Co. Tire Antitrust Litigation, 350 F. Supp. 1165, 1166 (J.P.M.L. 1972)</cite.query>; <cite.query w-src-number="0304914068" w-serial-number="1971104459" w-seq-number="00062" w-ref-type="RP" w-pub-number="0000345" ID="I6512dc456b3e11e99779f698461214a6">In re Air Fare Litigation, 322 F. Supp. 1013 (J.P.M.L. 1971)</cite.query>; <cite.query w-src-number="0304914068" w-serial-number="1970116047" w-seq-number="00063" w-ref-type="RP" w-pub-number="0000345" ID="I6512dc476b3e11e99779f698461214a6">In re Butterfield Patent Infringement, 328 F. Supp. 513 (J.P.M.L. 1970)</cite.query>. <eos/><bos/>The Northern District of Illinois is a particularly likely transferee district if the Panel considers geographic centrality.<eos/></paratext><eop/></para></footnote.body></footnote><footnote ID="If516d7516b3e11e99b03e53d6dd36aa2"><label.designator>4</label.designator><footnote.body><para><bop/><bos/><paratext><ital>See</ital> <cite.query w-src-number="0304914068" w-serial-number="2017252628" w-seq-number="00064" w-ref-type="RP" w-pub-number="0004637" ID="I6514b0f16b3e11e99779f698461214a6">In re Velocity Exp., Inc., Wage &amp; Hour Employment Practices Litigation, 581 F. Supp. 2d 1368 (J.P.M.L. 2008)</cite.query> (noting geographic dispersal of actions and nationwide business of defendant results in no “focal point” for litigation; transfer to centrally located Western District of Wisconsin); <cite.query w-src-number="0304914068" w-serial-number="2015333504" w-seq-number="00065" w-ref-type="RP" w-pub-number="0004637" ID="I6514b0f36b3e11e99779f698461214a6">In re Aurora Dairy Corp. Organic Milk Marketing and Sales Practices Litigation, 536 F. Supp. 2d 1369 (J.P.M.L. 2008)</cite.query>; <cite.query w-src-number="0304914068" w-serial-number="2010225831" w-seq-number="00066" w-ref-type="RP" w-pub-number="0004637" ID="I6514d8016b3e11e99779f698461214a6">In re Pharmacy Ben. Managers, 452 F. Supp. 2d 1352 (J.P.M.L. 2006)</cite.query>; <cite.query w-src-number="0304914068" w-serial-number="2009751429" w-seq-number="00067" w-ref-type="RP" w-pub-number="0004637" ID="I6514d8036b3e11e99779f698461214a6">In re Bausch &amp; Lomb Inc. Contact Lens Solution Products Liability Litigation, 444 F. Supp. 2d 1336 (J.P.M.L. 2006)</cite.query>; <cite.query w-src-number="0304914068" w-serial-number="2008318693" w-seq-number="00068" w-ref-type="RP" w-pub-number="0004637" ID="I6514d8056b3e11e99779f698461214a6">In re Viagra Products Liability Litigation, 414 F. Supp. 2d 1357 (J.P.M.L. 2006)</cite.query>; <cite.query w-src-number="0304914068" w-serial-number="2008553259" w-seq-number="00069" w-ref-type="RP" w-pub-number="0004637" ID="I6514d8076b3e11e99779f698461214a6">In re Celexa and Lexapro Products Liability Litigation, 416 F. Supp. 2d 1361 (J.P.M.L. 2006)</cite.query>; <cite.query w-src-number="0304914068" w-serial-number="2006243939" w-seq-number="00070" w-ref-type="RP" w-pub-number="0004637" ID="I6514d8096b3e11e99779f698461214a6">In re Vioxx Products Liability Litigation, 360 F. Supp. 2d 1352 (J.P.M.L. 2005)</cite.query>; <cite.query w-src-number="0304914068" w-serial-number="2002691945" w-seq-number="00071" w-ref-type="RP" w-pub-number="0004637" ID="I6514d80b6b3e11e99779f698461214a6">In re African-American Slave Descendants Litigation, 231 F. Supp. 2d 1357 (J.P.M.L. 2002)</cite.query>; <cite.query w-src-number="0304914068" w-serial-number="1972106905" w-seq-number="00072" w-ref-type="RP" w-pub-number="0000345" w-pinpoint-page="1166" ID="I6514d80d6b3e11e99779f698461214a6">In re Transit Co. Tire Antitrust Litigation, 350 F. Supp. 1165, 1166 (J.P.M.L. 1972)</cite.query>.<eos/></paratext><eop/></para></footnote.body></footnote><footnote ID="If516d7526b3e11e99b03e53d6dd36aa2"><label.designator>5</label.designator><footnote.body><para><bop/><bos/><paratext><cite.query w-src-number="0304914068" w-serial-number="2007566580" w-seq-number="00073" w-ref-type="RP" w-pub-number="0004637" ID="I651574416b3e11e99779f698461214a6">In re Rhodia S.A., Securities Litigation, 398 F. Supp. 2d 1359 (J.P.M.L. 2005)</cite.query>.<eos/></paratext><eop/></para></footnote.body></footnote><footnote ID="If516d7536b3e11e99b03e53d6dd36aa2"><label.designator>6</label.designator><footnote.body><para><bop/><bos/><paratext><cite.query w-src-number="0304914068" w-serial-number="2004322372" w-seq-number="00074" w-ref-type="RP" w-pub-number="0004637" w-pinpoint-page="1385" ID="I651637916b3e11e99779f698461214a6">In re Columbia University Patent Litigation, 313 F. Supp. 2d 1383, 1385 (J.P.M.L. 2004)</cite.query>. <eos/><bos/><ital>See also</ital> <cite.query w-src-number="0304914068" w-serial-number="2032795985" w-seq-number="00075" w-ref-type="RP" w-pub-number="0004637" ID="I651637936b3e11e99779f698461214a6">In re Solodyn (Minocycline Hydrochloride) Antitrust Litigation, 999 F. Supp. 2d 1383 (J.P.M.L. 2014)</cite.query> (noting convenience to numerous litigants); <cite.query w-src-number="0304914068" w-serial-number="2030714950" w-seq-number="00076" w-ref-type="RP" w-pub-number="0004637" ID="I651637956b3e11e99779f698461214a6">In re Suboxone (Buprenorphine Hydrochloride and Naloxone) Antitrust Litigation, 949 F. Supp. 2d 1365 (J.P.M.L. 2013)</cite.query> (Panel notes district is central between principal places of business of multiple defendants); <cite.query w-src-number="0304914068" w-serial-number="2001989029" w-seq-number="00077" w-ref-type="RP" w-pub-number="0004637" ID="I651637976b3e11e99779f698461214a6">In re Automotive Refinishing Paint Antitrust Litigation, 177 F. Supp. 2d 1378 (J.P.M.L. 2001)</cite.query> (“Northeast” was nexus of action).<eos/></paratext><eop/></para></footnote.body></footnote><footnote ID="If516fe606b3e11e99b03e53d6dd36aa2"><label.designator>7</label.designator><footnote.body><para><bop/><bos/><paratext><cite.query w-src-number="0304914068" w-serial-number="2001473390" w-seq-number="00078" w-ref-type="RP" w-pub-number="0004637" w-pinpoint-page="1381" ID="I651749016b3e11e99779f698461214a6">In re American General Life and Accident Ins. Co. Industrial Life Ins. Litigation, 175 F. Supp. 2d 1380, 1381 (J.P.M.L. 2001)</cite.query>. <eos/><bos/><ital>See also</ital> <cite.query w-src-number="0304914068" w-serial-number="2037790571" w-seq-number="00079" w-ref-type="RP" w-pub-number="0007903" w-pinpoint-page="1382" ID="I651749036b3e11e99779f698461214a6">In re Medical Informatics Engineering, Inc., Customer Data Security Breach Litigation, 148 F. Supp. 3d 1381, 1382 (J.P.M.L. 2015)</cite.query> (E.D. Mo. chosen because of “Midwestern tilt” of litigation); <cite.query w-src-number="0304914068" w-serial-number="2014131282" w-seq-number="00080" w-ref-type="RP" w-pub-number="0004637" ID="I651749056b3e11e99779f698461214a6">In re Papst Licensing Digital Camera Patent Litigation, 528 F. Supp. 2d 1357 (U.S.J.P.M.L. 2007)</cite.query>.<eos/></paratext><eop/></para></footnote.body></footnote><footnote ID="If516fe616b3e11e99b03e53d6dd36aa2"><label.designator>8</label.designator><footnote.body><para><bop/><bos/><paratext><ital>See, e.g.</ital>, <cite.query w-src-number="0304914068" w-serial-number="2005787867" w-seq-number="00081" w-ref-type="RP" w-pub-number="0004637" ID="I6517e5416b3e11e99779f698461214a6">In re Parmalat Securities Litigation, 350 F. Supp. 2d 1356 (J.P.M.L. 2004)</cite.query> (New York selected for litigation involving Italian defendant).<eos/></paratext><eop/></para></footnote.body></footnote><footnote ID="If516fe626b3e11e99b03e53d6dd36aa2"><label.designator>9</label.designator><footnote.body><para><bop/><bos/><paratext><ital>See generally</ital> <cite.query w-src-number="0304914068" w-serial-number="2031813066" w-seq-number="00082" w-ref-type="RP" w-pub-number="0004637" ID="I6518cfa16b3e11e99779f698461214a6">In re Vehicle Carrier Services Antitrust Litigation, 978 F. Supp. 2d 1382 (J.P.M.L. 2013)</cite.query> (litigation described as “bi-coastal,” but District of New Jersey chosen for ease of accessibility); <cite.query w-src-number="0304914068" w-serial-number="1980102705" w-seq-number="00083" w-ref-type="RP" w-pub-number="0000345" w-pinpoint-page="822" ID="I6518cfa36b3e11e99779f698461214a6">In re Resource Exploration, Inc., Securities Litigation, 483 F. Supp. 817, 822–23 (J.P.M.L. 1980)</cite.query> (New York more “accessible” than Louisiana); <cite.query w-src-number="0304914068" w-serial-number="1972106905" w-seq-number="00084" w-ref-type="RP" w-pub-number="0000345" w-pinpoint-page="1166" ID="I6518cfa56b3e11e99779f698461214a6">In re Transit Co. Tire Antitrust Litigation, 350 F. Supp. 1165, 1166 (J.P.M.L. 1972)</cite.query>. <eos/><bos/><ital>But see</ital> <cite.query w-src-number="0304914068" w-serial-number="1972105062" w-seq-number="00085" w-ref-type="RP" w-pub-number="0000345" ID="I6518cfa76b3e11e99779f698461214a6">In re Career Academy Antitrust Litigation, 342 F. Supp. 753 (J.P.M.L. 1972)</cite.query> (travel not compelling factor).<eos/></paratext><eop/></para></footnote.body></footnote><footnote ID="If516fe636b3e11e99b03e53d6dd36aa2"><label.designator>10</label.designator><footnote.body><para><bop/><bos/><paratext> <cite.query w-src-number="0304914068" w-serial-number="2008951957" w-seq-number="00086" w-ref-type="RP" w-pub-number="0004637" ID="I651a56416b3e11e99779f698461214a6">In re Jamster Marketing Litigation, 427 F. Supp. 2d 1366 (J.P.M.L. 2006)</cite.query>.<eos/><bos/><cite.query w-src-number="0304914068" w-serial-number="2007685144" w-seq-number="00087" w-ref-type="RP" w-pub-number="0004637" ID="I651a56436b3e11e99779f698461214a6">In re Guidant Corp. Implantable Defibrillators Products Liability Litigation, 398 F. Supp. 2d 1371 (J.P.M.L. 2005)</cite.query>; <cite.query w-src-number="0304914068" w-serial-number="2007566580" w-seq-number="00088" w-ref-type="RP" w-pub-number="0004637" ID="I651a56456b3e11e99779f698461214a6">In re Rhodia S.A., Securities Litigation, 398 F. Supp. 2d 1359 (J.P.M.L. 2005)</cite.query>; <cite.query w-src-number="0304914068" w-serial-number="2006265212" w-seq-number="00089" w-ref-type="RP" w-pub-number="0004637" ID="I651a56476b3e11e99779f698461214a6"><ital>In re Insurance Brokerage Antitrust Litigation</ital>, 360 F. Supp. 2d 1371 (J.P.M.L. 2005)</cite.query> (access accessible metropolitan forum); <cite.query w-src-number="0304914068" w-serial-number="2006265247" w-seq-number="00090" w-ref-type="RP" w-pub-number="0004637" ID="I651a56496b3e11e99779f698461214a6"><ital>In re Compression Labs, Inc., Patent Litigation</ital>, 360 F. Supp. 2d 1367 (J.P.M.L. 2005)</cite.query> (same); <cite.query w-src-number="0304914068" w-serial-number="2005839846" w-seq-number="00091" w-ref-type="RP" w-pub-number="0004637" ID="I651a564b6b3e11e99779f698461214a6">In re Educational Testing Service PLT 7-12 Test Scoring Litigation, 350 F. Supp. 2d 1363 (J.P.M.L. 2004)</cite.query> (transfer to accessible, metropolitan district); <cite.query w-src-number="0304914068" w-serial-number="1978122164" w-seq-number="00092" w-ref-type="RP" w-pub-number="0000345" ID="I651a564d6b3e11e99779f698461214a6">In re First Nat. Bank, Heavener, Okl. (First Mortg. Revenue Bonds) Securities Litigation, 451 F. Supp. 995 (J.P.M.L. 1978)</cite.query>.<eos/></paratext><eop/></para></footnote.body></footnote><footnote ID="If51725706b3e11e99b03e53d6dd36aa2"><label.designator>11</label.designator><footnote.body><para><bop/><bos/><paratext><ital>See, e.g.</ital>, <cite.query w-src-number="0304914068" w-serial-number="1978103945" w-seq-number="00093" w-ref-type="RP" w-pub-number="0000345" w-pinpoint-page="1350" ID="I651b67b16b3e11e99779f698461214a6">In re Wiring Device Antitrust Litigation, 444 F. Supp. 1348, 1350 (J.P.M.L. 1978)</cite.query>. <eos/><bos/>The Panel&apos;s preference for transferring cases to a district that permits coordination with other federal litigation is discussed in §§ <cite.query w-ref-type="NA" w-normalized-cite="MDLITMANs5:25" w-pub-number="185218" ID="If51725716b3e11e99b03e53d6dd36aa2">5:25</cite.query> and  <cite.query w-ref-type="NA" w-normalized-cite="MDLITMANs6:12" w-pub-number="185218" ID="If51725726b3e11e99b03e53d6dd36aa2">6:12</cite.query>.<eos/></paratext><eop/></para></footnote.body></footnote><footnote ID="If51725736b3e11e99b03e53d6dd36aa2"><label.designator>12</label.designator><footnote.body><para><bop/><bos/><paratext><ital>See</ital> <cite.query w-src-number="0304914068" w-serial-number="1992137612" w-seq-number="00094" w-ref-type="RP" w-pub-number="0000345" ID="I651bb5d16b3e11e99779f698461214a6">In re Air Disaster Near Brunswick, Ga., on Apr. 5, 1991, 794 F. Supp. 393 (J.P.M.L. 1992)</cite.query>.<eos/></paratext><eop/></para></footnote.body></footnote><footnote ID="If51725746b3e11e99b03e53d6dd36aa2"><label.designator>13</label.designator><footnote.body><para><bop/><bos/><paratext><ital>See</ital> <cite.query w-src-number="0304914068" w-serial-number="2003835670" w-seq-number="00095" w-ref-type="RP" w-pub-number="0004637" ID="I651c2b016b3e11e99779f698461214a6">In re Western States Wholesale Natural Gas Antitrust Litigation, 290 F. Supp. 2d 1376 (J.P.M.L. 2003)</cite.query>.<eos/></paratext><eop/></para></footnote.body></footnote><footnote ID="If51725756b3e11e99b03e53d6dd36aa2"><label.designator>14</label.designator><footnote.body><para><bop/><bos/><paratext><ital>See, e.g.</ital>, <cite.query w-src-number="0304914068" w-serial-number="2044244569" w-seq-number="00096" w-ref-type="RP" w-pub-number="0007903" ID="I651cee516b3e11e99779f698461214a6">In re Apple Inc. Device Performance Litigation, 291 F. Supp. 3d 1371 (U.S.J.P.M.L. 2018)</cite.query> (describing forum as convenient and accessible); <cite.query w-src-number="0304914068" w-serial-number="2043740151" w-seq-number="00097" w-ref-type="RP" w-pub-number="0007903" ID="I651cee536b3e11e99779f698461214a6">In re Dealer Management Systems Antitrust Litigation, 291 F. Supp. 3d 1367 (U.S.J.P.M.L. 2018)</cite.query>; <cite.query w-src-number="0304914068" w-serial-number="2043740157" w-seq-number="00098" w-ref-type="RP" w-pub-number="0007903" ID="I651cee556b3e11e99779f698461214a6">In re Onglyza (Saxagliptin) and Kombiglyze XR (Saxagliptin and Metformin) Products Liability Litigation, 289 F. Supp. 3d 1357 (U.S.J.P.M.L. 2018)</cite.query>; <cite.query w-src-number="0304914068" w-serial-number="2043740377" w-seq-number="00099" w-ref-type="RP" w-pub-number="0007903" ID="I651cee576b3e11e99779f698461214a6">In re General Motors Corp. Air Conditioning Marketing and Sales Practices Litigation, 289 F. Supp. 3d 1340 (U.S.J.P.M.L. 2018)</cite.query> (accessible and convenient); <cite.query w-src-number="0304914068" w-serial-number="2043740563" w-seq-number="00100" w-ref-type="RP" w-pub-number="0007903" ID="I651cee596b3e11e99779f698461214a6">In re Restasis (Cyclosporine Ophthalmic Emulsion) Antitrust Litigation, 289 F. Supp. 3d 1332 (U.S.J.P.M.L. 2018)</cite.query> (same); <cite.query w-src-number="0304914068" w-serial-number="2012539199" w-seq-number="00101" w-ref-type="RP" w-pub-number="0004637" ID="I651d15616b3e11e99779f698461214a6">In re Rembrandt Technologies, LP, Patent Litigation, 493 F. Supp. 2d 1367 (J.P.M.L. 2007)</cite.query>; <cite.query w-src-number="0304914068" w-serial-number="2011162453" w-seq-number="00102" w-ref-type="RP" w-pub-number="0004637" ID="I651d15636b3e11e99779f698461214a6">In re Stand &apos;n Seal Products, 469 F. Supp. 2d 1351 (J.P.M.L. 2007)</cite.query>; <cite.query w-src-number="0304914068" w-serial-number="2010986583" w-seq-number="00103" w-ref-type="RP" w-pub-number="0004637" ID="I651d15656b3e11e99779f698461214a6">In re LLRICE 601 Contamination Litigation, 466 F. Supp. 2d 1351 (J.P.M.L. 2006)</cite.query> <cite.query w-src-number="0304914068" w-serial-number="2003857699" w-seq-number="00104" w-ref-type="RP" w-pub-number="0004637" ID="I651d15676b3e11e99779f698461214a6">In re Wireless Telephone Federal Cost Recovery Fees Litigation, 293 F. Supp. 2d 1378 (J.P.M.L. 2003)</cite.query>; <cite.query w-src-number="0304914068" w-serial-number="2003324064" w-seq-number="00105" w-ref-type="RP" w-pub-number="0004637" ID="I651d15696b3e11e99779f698461214a6">In re Gator Corp. Software Trademark &amp; Copyright Litigation, 259 F. Supp. 2d 1378 (J.P.M.L. 2003)</cite.query>.<eos/></paratext><eop/></para></footnote.body></footnote></footnote.block><content.metadata.block><cmd.royalty><cmd.copyright><bop/><bos/>Westlaw. © 2019 Thomson Reuters.  <eos/><bos/>No Claim to Orig. U.S. Govt. <eos/><bos/>Works.<eos/><eop/></cmd.copyright></cmd.royalty><cmd.identifiers><cmd.cites><cmd.first.line.cite><bop/><bos/>MDLITMAN § 6:7<eos/><eop/></cmd.first.line.cite></cmd.cites></cmd.identifiers></content.metadata.block></doc></n-docbody>
